Logo-bi
Original Research
Fatemeh Khonsari ORCID, Mostafa Heydari ORCID, Rassoul Dinarvand ORCID, Mohammad Sharifzadeh ORCID, Fatemeh Atyabi* ORCID
Bioimpacts. 2022;12(1): 21-32. doi: 10.34172/bi.2021.23389
PMCID: PMC8783081     PMID: 35087713     Scopus ID: 85127207881    
Nanostructured-Lipid-Carriers (NLCs) for brain delivery of rapamycin were designed by modification of optimized cationic-NLCs (C-NLC) with different approaches. The targeted transferrin decorated NLCs(Tf-NLCs) in comparison to untargeted bare-NLCs (B-NLCs) showed higher cellular uptake and appropriate targeted accumulation in the brain.
Short Communication
Maryam Moazeni ORCID, Majid Saeedi ORCID, Hamidreza Kelidari ORCID, Behrad Roohi, Mohammad T Hedayati ORCID, Tahereh Shokohi ORCID, Mojtaba Nabili ORCID, Kofi Asare-Addo ORCID, Ali Nokhodchi* ORCID
BioImpacts. 2022;12(6): 561-566. doi: 10.34172/bi.2022.23825
PMCID: PMC9809133     PMID: 36644547     Scopus ID: 85143320810    
Due to the occurrence of fluconazole resistance to Candida glabrata, four resistant as well as one standard isolates were exposed to fluconazole loaded nanostructured lipid carrier alongside conventional fluconazole. These data represent the possible changes in efflux pumps genes expression.
Original Article
Saman Heydari ORCID, Mohammad Barzegar-Jalali, Mostafa Heydari, Afsaneh Radmehr, Ana Cláudia Paiva-Santos, Maryam Kouhsoltani, Hamed Hamishehkar* ORCID
Bioimpacts. 2024;14(6): 30243. doi: 10.34172/bi.2024.30243
PDF
XML
Cited By: